News & Media
Posters AACR 2023
Posters SITC 2022
Search on our website
Type Enter to start searching.
Scroll to explore
Latest press releases
Scroll back top
18 July 2023
Domain Therapeutics announces the European Patent Office decision to grant a patent for its propriet...
29 June 2023
Domain Therapeutics announces nomination of best-in-class CCR8 antibody candidate, DT-7012, further ...
5 June 2023
Domain Therapeutics announces nomination of first-in-class PAR2 NAM candidate, DT-9045, to unlock n...
6 April 2023
Domain Therapeutics to present three posters at AACR 2023 annual meeting
6 February 2023
Domain Therapeutics to Participate in Upcoming Investor and Industry Conferences
5 January 2023
Domain Therapeutics announces first patient dosed with DT-9081 in phase I clinical study in patients...
8 December 2022
Domain Therapeutics strengthens Scientific Advisory Board with appointment of immuno-oncology expert...
10 November 2022
Domain Therapeutics presents new data on its EP4R and CCR8 antagonists at 2022 SITC Annual Meeting
19 October 2022
Domain Therapeutics to progress into clinical trials with its EP4R antagonist DT-9081 in solid tumor...
6 October 2022
Domain Therapeutics to present new data on its EP4R and CCR8 antagonists at 2022 SITC Annual Meetin...
News & Media